Wang Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wang Shen has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Bin Sun
College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
3 shared publications - Hongmei Xia
College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
3 shared publications - Lu Wang
College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
3 shared publications - Yongli Zhang
College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
3 shared publications - Keang Cao
College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
2 shared publications - Si Shen
College of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China
2 shared publications
Latest Publications
- Open Access
Liposomes-in-Gel as the Docetaxel Delivery for the Effective Treatment of Psoriasis by Inhibiting the Proliferation of Blood Vessels
Psoriasis is a chronic skin disease caused by the interaction of multiple factors that leads to the abnormal growth of stratum corneum cells and has been called an immortal cancer. Docetaxel has been trialed for the treatment of psoriasis due to its superior ability to induce apoptosis, but its insolubility and low bioavailability have hampered its development. Here, docetaxel (DTX)-loaded liposomes-in-gel (DTX-LP-G) as the transdermal delivery was investigated to the treatment of psoriasis via modulating the IL6-HIF-1α-VEGF axis. The results demonstrated that DTX-LP-G cumulatively released a much higher amount of drug into the skin than that from DTX-loaded liposomes (DTX-LPs) and DTX-loaded gel (DTX-G). DTX-LP-G was also the most efficient in scavenging hydrogen peroxide free radicals in vitro. In a mouse model of psoriasis, DTX-LP-G acted as a preliminary therapeutic agent for psoriasis in terms of apparent evaluation, splenomegaly, suppression of MDA content in skin tissue, and down-regulated the expression of IL6, HIF-1α, and VEGF to control the proliferation of vessels, except for a less pronounced effect on the stratum corneum. In addition, enrichment analysis can speculate that DTX also treated psoriasis by resisting the production of keratin-forming cells.
Open AccessLiposomes-in-Gel as the Docetaxel Delivery for the Effective Treatment of Psoriasis by Inhibiting the Proliferation of Blood Vessels
Psoriasis is a chronic skin disease caused by the interaction of multiple factors that leads to the abnormal growth of stratum corneum cells and has been called an immortal cancer. Docetaxel has been trialed for the treatment of psoriasis due to its superior ability to induce apoptosis, but its insolubility and low bioavailability have hampered its development. Here, docetaxel (DTX)-loaded liposomes-in-gel (DTX-LP-G) as the transdermal delivery was investigated to the treatment of psoriasis via modulating the IL6-HIF-1α-VEGF axis. The results demonstrated that DTX-LP-G cumulatively released a much higher amount of drug into the skin than that from DTX-loaded liposomes (DTX-LPs) and DTX-loaded gel (DTX-G). DTX-LP-G was also the most efficient in scavenging hydrogen peroxide free radicals in vitro. In a mouse model of psoriasis, DTX-LP-G acted as a preliminary therapeutic agent for psoriasis in terms of apparent evaluation, splenomegaly, suppression of MDA content in skin tissue, and down-regulated the expression of IL6, HIF-1α, and VEGF to control the proliferation of vessels, except for a less pronounced effect on the stratum corneum. In addition, enrichment analysis can speculate that DTX also treated psoriasis by resisting the production of keratin-forming cells.
- Open Access
Investigation of the Anti-Inflammatory and Anti-Oxidant Activities of a Novel Kaempferol-Liposome-Loaded Hydrogel for the Treatment of Acute Eczema
Kaempferol liposome hydrogel is a novel drug carrier designed to solve the problems of the poor water solubility and low bioavailability of kaempferol. By combining kaempferol with liposomes and further forming a hydrogel, this composite formulation not only improves the stability of the drug but also enhances its penetration and therapeutic effect on the skin. It was demonstrated that the liposomal hydrogel of kaempferol had ex vivo and in vivo antioxidant activities, which could effectively inhibit the inflammatory response and oxidative stress and, thus, showed significant efficacy in the treatment of acute eczema. In the acute eczema model, kaempferol liposome hydrogel significantly improved the skin condition of mice by reducing the symptoms of skin redness, swelling, and itching. The experimental results showed that the hydrogel was rapidly absorbed into the skin after application and continued to release the drug to maintain its efficacy for a longer period of time. In addition, the kaempferol liposome hydrogel also showed good physicochemical stability and was not easily discolored or separated, making it suitable for long-term use. As an innovative drug carrier for the treatment of acute eczema, the kaempferol liposome hydrogel shows good application prospects and provides a new treatment option for eczema patients.
Open AccessInvestigation of the Anti-Inflammatory and Anti-Oxidant Activities of a Novel Kaempferol-Liposome-Loaded Hydrogel for the Treatment of Acute Eczema
Kaempferol liposome hydrogel is a novel drug carrier designed to solve the problems of the poor water solubility and low bioavailability of kaempferol. By combining kaempferol with liposomes and further forming a hydrogel, this composite formulation not only improves the stability of the drug but also enhances its penetration and therapeutic effect on the skin. It was demonstrated that the liposomal hydrogel of kaempferol had ex vivo and in vivo antioxidant activities, which could effectively inhibit the inflammatory response and oxidative stress and, thus, showed significant efficacy in the treatment of acute eczema. In the acute eczema model, kaempferol liposome hydrogel significantly improved the skin condition of mice by reducing the symptoms of skin redness, swelling, and itching. The experimental results showed that the hydrogel was rapidly absorbed into the skin after application and continued to release the drug to maintain its efficacy for a longer period of time. In addition, the kaempferol liposome hydrogel also showed good physicochemical stability and was not easily discolored or separated, making it suitable for long-term use. As an innovative drug carrier for the treatment of acute eczema, the kaempferol liposome hydrogel shows good application prospects and provides a new treatment option for eczema patients.
- Open Access
Curcumin-Loaded Liposomes in Gel Protect the Skin of Mice against Oxidative Stress from Photodamage Induced by UV Irradiation
Prolonged exposure to ultraviolet (UV) irradiation can cause oxidative stress in the skin, accompanied by rapid immunosuppressive effects, resulting in a peroxidation reaction throughout the body. Curcumin (Cur), as the bioactive compound of turmeric, is a natural polyphenol with potent antioxidant properties but is often overlooked due to its poor solubility and low bioavailability. In this study, curcumin-loaded liposomes in a sodium alginate gel complex preparation were designed to improve the bioavailability of curcumin and to study its preventive effect on photodamage. Cur-loaded liposomes (Cur-L), Cur-loaded gel (Cur-G) based on an alginate matrix, and curcumin-loaded liposomes in gel (Cur-LG) were prepared, and their antioxidant effects and drug diffusion abilities were evaluated. The antioxidant capacity of Cur, Cur-L, Cur-G, and Cur-LG was also studied in a mouse model of photodamage. Cur had the highest antioxidant activity at about 4 mg/mL. Cur-LG at this concentration showed antioxidant effects during 1,1-diphenyl-2-trinitrophenylhydrazine (DPPH) and H2O2 experiments. During the UV light damage test, Cur-LG demonstrated the ability to effectively neutralize free radicals generated as a result of lipid peroxidation in the skin, serum, and liver, thereby enhancing the overall activity of superoxide dismutase (SOD). In conclusion, using Cur-LG may protect against epidermal and cellular abnormalities induced by UV irradiation.
Open AccessCurcumin-Loaded Liposomes in Gel Protect the Skin of Mice against Oxidative Stress from Photodamage Induced by UV Irradiation
Prolonged exposure to ultraviolet (UV) irradiation can cause oxidative stress in the skin, accompanied by rapid immunosuppressive effects, resulting in a peroxidation reaction throughout the body. Curcumin (Cur), as the bioactive compound of turmeric, is a natural polyphenol with potent antioxidant properties but is often overlooked due to its poor solubility and low bioavailability. In this study, curcumin-loaded liposomes in a sodium alginate gel complex preparation were designed to improve the bioavailability of curcumin and to study its preventive effect on photodamage. Cur-loaded liposomes (Cur-L), Cur-loaded gel (Cur-G) based on an alginate matrix, and curcumin-loaded liposomes in gel (Cur-LG) were prepared, and their antioxidant effects and drug diffusion abilities were evaluated. The antioxidant capacity of Cur, Cur-L, Cur-G, and Cur-LG was also studied in a mouse model of photodamage. Cur had the highest antioxidant activity at about 4 mg/mL. Cur-LG at this concentration showed antioxidant effects during 1,1-diphenyl-2-trinitrophenylhydrazine (DPPH) and H2O2 experiments. During the UV light damage test, Cur-LG demonstrated the ability to effectively neutralize free radicals generated as a result of lipid peroxidation in the skin, serum, and liver, thereby enhancing the overall activity of superoxide dismutase (SOD). In conclusion, using Cur-LG may protect against epidermal and cellular abnormalities induced by UV irradiation.